EXAGEN INC. - Common Stock, par value $0.001 per share (XGN)

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
22,037,221
Total 13F shares
8,530,317
Share change
+4,251,176
Total reported value
$148,995,938
Price per share
$17.50
Number of holders
55
Value change
+$74,473,606
Number of buys
39
Number of sells
11

Institutional Holders of EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) as of Q1 2021

As of 31 Mar 2021, EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) was held by 55 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,530,317 shares. The largest 10 holders included WASATCH ADVISORS INC, RTW INVESTMENTS, LP, COWEN AND COMPANY, LLC, PLATINUM INVESTMENT MANAGEMENT LTD, Nantahala Capital Management, LLC, NOMURA HOLDINGS INC, PURA VIDA INVESTMENTS, LLC, SILVERCREST ASSET MANAGEMENT GROUP LLC, BlackRock Inc., and BANK OF MONTREAL /CAN/. This page lists 55 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.